Artemis Hospitals
In India, immunotherapy with Keytruda typically costs from AUD $4,968 to AUD $8,801 per session. The final price depends on the required dosage per vial, hospital tier, and city. In Australia, patients often face costs of AUD $11,214 for similar treatments when not covered by the PBS. By choosing India, Australians can save approximately 38% while receiving care at JCI-accredited facilities.
Bookimed Expert Insight: Australian patients can find exceptional value at high-volume centres like HCG Manavata Cancer Centre. This facility has treated over 100,000 global patients and features specialists like Dr. Raj Nagarkar. Choosing larger networks such as Apollo Hospital Indraprastha or Manipal Hospitals ensures access to advanced diagnostics. These hubs often offer the latest immunotherapy protocols at a fraction of Australian private healthcare rates.
| India | Thailand | Turkey | |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $4,968 | from AUD $11,356 | from AUD $4,685 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.
The doctor is an MDS in Oral & Maxillofacial Surgery with 3 years of experience in Surgical Oncology at the HCG Manavata Cancer Centre in Nasik.
Specializes in oral cancer, focusing on organ preservation and functional rehabilitation. Has a strong interest in preventive oral hygiene and early diagnosis of oral cancers.
Proficient in major maxillofacial and head & neck surgeries and has completed fellowship training in Head & Neck Surgical Oncology from HCG Manavata Cancer Centre.
Active researcher with numerous publications.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
The doctor received Surgical Oncology training at Tata Memorial Hospital, Mumbai, and completed MRCS at the Royal College of Surgeons, Edinburgh. Starting practice in 2000, the doctor founded Curie Manavata Cancer Centre in 2007. With 19 years of experience, the doctor has performed over 50,000 cancer surgeries and participated in more than 200 clinical trials. The doctor is a published author with numerous international and national publications. Specializing in Breast and Thoracic Surgical Oncology, the doctor is a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at MUHS.
The doctor is a highly experienced hematology-oncologist at HCG Manavata Cancer Centre, Nashik, with over 13 years of expertise in leukemia, multiple myeloma, and bone marrow transplant.
Graduated with an MBBS degree from Grant Medical College and Sir JJ Hospital, the doctor further pursued an MD in Pathology from Lokmanya Tilak Municipal Medical College, Sion, and Mumbai.
Additionally, the doctor holds a DM in Clinical Hematology from Medical College, Calcutta, and has received awards for professionalism and hard work, underscoring a reputation as a competent and skilled specialist.